LIU Jun-Yan. Application of Imaging Evaluation of Collateral Circulation in Diagonosis and Treatment of Stroke[J]. Chinese Journal of Stroke, 2019, 14(07): 635-638.
[1] LIEBESKIND D S. Reperfusion for acute ischemicstroke:arterial revascularization and collateraltherapeutics[J]. Curr Opin Neurol,2010,23(1):36-45.[2] MITEFF F,LEVI C R,BATEMAN G A,et al.The independent predictive utility of computedtomography angiographic collateral status in acuteischaemic stroke[J]. Brain,2009,132(Pt 8):2231-2238.[3] BANG O Y,SAVER J L,KIM S J,et al. Collateralflow averts hemorrhagic transformation afterendovascular therapy for acute ischemic stroke[J].Stroke,2011,42(8):2235-2239.[4] BERKHEMER O A,FRANSEN P S,BEUMER D,et al. A randomized trial of intraarterial treatmentfor acute ischemic stroke[J]. N Engl J Med,2015,372(1):11-20.[5] GOYAL M,DEMCHUK A M,MENON B K,etal. Randomized assessment of rapid endovasculartreatment of ischemic stroke[J]. N Engl J Med,2015,372(11):1019-1030.[6] CAMPBELL B C V,MITCHELL P J,YAN B,etal. A Multicenter,Randomized,Controlled Study toInvestigate Extending the Time for Thrombolysis inEmergency Neurological Deficits with Intra-ArterialTherapy(EXTEND-IA)[J]. In J Stroke,2013,9(1):126-132.[7] SAVER J L,GOYAL M,BONAFE A,et al. Stentretrieverthrombectomy after intravenous t-PA vs .t-PA alone in stroke[J]. N Engl J Med,2015,372(24):2285-2295.[8] NOGUEIRA R G,JADHAV A P,HAUSSEN D C,et al. Thrombectomy 6 to 24 hours after stroke witha mismatch between deficit and infarct[J]. N Engl JMed,2018,378(1):11-21.[9] ALBERS G W,MARKS M P,KEMP S,et al.Thrombectomy for stroke at 6 to 16 hours withselection by perfusion imaging[J]. N Engl J Med,2018,378(8):708-718.[10] EDWARD C J,JEFFREY L S,HAROLD P A,et al.Guidelines for the early management of patients withacute ischemic stroke:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J]. Stroke,2013,8(3):870-947.[11] 黄家星,林文华,刘丽萍,等. 缺血性卒中侧支循环评估与干预中国专家共识[J]. 中国卒中杂志,2013,8(4):285-293.[12] 中国卒中学会脑血流与代谢分会. 缺血性卒中脑侧支循环评估与干预中国指南(2017)[J]. 中华内科杂志,2017,6(56):460-471.[13] POWERS W J,CLARKE W R,GRUBB R L,et al.Extracranial-intracranial bypass surgery for strokeprevention in hemodynamic cerebral ischemia:theCarotid Occlusion Surgery Study randomized trial[J].JAMA,2011,306(18):1983-1992.[14] LIN W,XIONG L,HAN J,et al. Externalcounterpulsation augments blood pressure andcerebral flow velocities in ischemic stroke patientswith cerebral intracranial large artery occlusivedisease[J]. Stroke,2012,43(11):3007-3011.[15] XIONG L,LIN W,HAN J,et al. A retrospectivepilot study of correlation of cerebral augmentationeffects of external counterpulsation with functionaloutcome after acute ischaemic stroke[J/OL]. BMJOpen,2015,5(9):e009233. https://doi.org/10.1136/bmjopen-2015-009233.[16] BRUNSER A M,MUÑOZ VENTURELLI P,LAVADOS P M,et al. Head position and cerebralblood flow in acute ischemic stroke patients:protocolfor the pilot phase,cluster randomized,HeadPosition in Acute Ischemic Stroke Trial(Head PoSTpilot)[J]. Int J Stroke,2016,11(2):253-259.[17] RUDOLF J. Hydroxyethyl starch for hypervolemichemodilution in patients with acute ischemic stroke:a randomized,placebo-controlled phase Ⅱ safetystudy[J]. Cerebrovascular Diseases,2002,14(1):33-41.[18] GINSBERG M D,PALESCH Y Y,HILL M D,etal. High-dose albumin treatment for acute ischaemicstroke(ALIAS)part 2:a randomised,double-blind,phase 3,placebo-controlled trial[J]. Lancet Neurol,2013,12(11):1049-1058.[19] SHUAIB A,BORNSTEIN N M,DIENER H C,etal. Partial aortic occlusion for cerebral perfusionaugmentation[J]. Stroke,2011,42(6):1680-1690.[20] OVBIAGELE B,SAVER J L,STARKMAN S,etal. Statin enhancement of collateralization in acutestroke[J]. Neurology,2007,68(24):2129-2131.[21] LEE M J,BANG O Y,KIM S J,et al. Role of statinin atrial fibrillation-related stroke:an angiographicstudy for collateral flow[J]. Cerebrovascular Diseases,2014,37(2):77-84.[22] LIU C L,LIAO S J,ZENG J S,et al. dl-3nbutylphthalideprevents stroke via improvement ofcerebral microvessels in RHRSP[J]. J Neurol Sci,2007,260(1-2):106-113.[23] QIN C,ZHOU P,WANG L,et al. Dl-3-Nbutylphthalideattenuates ischemic reperfusioninjury by improving the function of cerebralartery and circulation[J/OL]. J Cereb Blood FlowMetab,2018:271678X18776833. https://doi.org/10.1177/0271678X18776833.
[24] XIONG Z,LU W,ZHU L,et al. Dl-3-nbutylphthalidetreatment enhances hemodynamicsand ameliorates memory deficits in rats withchronic cerebral hypoperfusion[J/OL]. Front AgingNeurosci,2017,9:238. https://doi.org/10.3389/fnagi.2017.00238.[25] 龚浠平. 尤瑞克林改善脑血管储备能力的研究[J]. 中国卒中杂志,2007,2(6):91-94.[26] MIAO J,DENG F,ZHANG Y,et al. Exogenoushuman urinary kallidinogenase increases cerebralblood flow in patients with acute ischemic stroke[J].Neurosciences,2016,21(2):126-130.[27] YE Q,ZEILER S R,SAEEDEH M,et al.Intracranial plaque enhancement in patients withcerebrovascular events on high-spatial-resolutionMR images[J]. Radiology,2014,271(2):534-542.[28] SKARPATHIOTAKIS M,MANDELL D M,SWARTZ R H,et al. Intracranial atheroscleroticplaque enhancement in patients with ischemicstroke[J]. AJNR Am J Neuroradiol,2013,34(2):299-304.[29] VAKIL P,VRANIC J,HURLEY M C,etal. T1 gadolinium enhancement of intracranialatherosclerotic plaques associated with symptomaticischemic presentations[J]. Am J Neuroradiol,2013,34(12):2252-2258.